All In MedTech

Device Trial Radar · NCT01091129

Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis

Last checked: Nov 19, 2026Latest source record: Dec 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Feb 2010

Primary completion

Jan 2011

Study completion Jan 2012

Sponsor

Lead sponsor
Miramar LabsNot on our public-company list
Sponsor type
Industry
First posted
Mar 23, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether treatment by the miraDry System can safely reduce the severity of axillary hyperhidrosis (excessive underarm sweating).

Conditions

  • Axillary Hyperhidrosis

Interventions

  • miraDry System (treatment with energy)Device

    Treatment with microwave energy delivery device as specified by manufacturer's instructions

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of subjects that rate themselves as HDSS of 1 or 2 at the 30 day follow-up visit will be greater than 50% with a 95% confidence.Time frame: 30 days after final treatment session
  2. Rate of serious adverse eventsTime frame: 12 months post treatment

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Guildford Dermatology Specialists

    Surrey, British Columbia, Canada

  • Cosmedica

    Victoria, British Columbia, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.